Real-world data in the United Kingdom: opportunities and challenges

被引:27
作者
McDonald, Laura [1 ]
Lambrelli, Dimitra [1 ]
Wasiak, Radek [1 ]
Ramagopalan, Sreeram V. [1 ]
机构
[1] Evidera, Metro Bldg,6th Floor,1 Butterwick, London W6 8DL, England
来源
BMC MEDICINE | 2016年 / 14卷
关键词
Real-world evidence; Care.data; United Kingdom; MEDICAL-RESEARCH; OPT-OUT; REGISTRY; CONSENT; TRIAL;
D O I
10.1186/s12916-016-0647-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Real-world data is that collected outside the constraints of controlled clinical trials and is increasingly informing decision-making in healthcare. The landscape of real-world data in the United Kingdom is set to evolve over the coming months as the government plans to build on databases currently in place by collecting patient data from all family practices and linking this information with hospital records. This initiative, called care. data, has the potential to be an invaluable resource. However, the programme has been criticized on grounds of data privacy, which has led to an extended delay in its implementation and the expectation that a large number of people will opt out. Opt-outs may introduce substantial biases to the dataset, and understanding how to account for these presents a significant challenge for researchers. For the scope and quality of real-world evidence in the United Kingdom to be realised, and for this information to be used effectively, it is essential to address this challenge.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Conundrum of Using Real-World Observational Data to Inform Real-World Conclusions About Safety and Efficacy
    Gibson, C. Michael
    Nafee, Tarek
    Kerneis, Mathieu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (15) : 1801 - 1803
  • [32] Drug repurposing using real-world data
    Tan, George S. Q.
    Sloan, Erica K.
    Lambert, Pete
    Kirkpatrick, Carl M. J.
    Ilomaki, Jenni
    DRUG DISCOVERY TODAY, 2023, 28 (01) : 10 - 13
  • [33] Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence
    Helanterae, Ilkka
    Snyder, Jon
    asberg, Anders
    Cruzado, Josep Maria
    Bell, Samira
    Legendre, Christophe
    Tedesco-Silva, Helio
    Barcelos, Giovanna Tedesco
    Geissbuehler, Yvonne
    Prieto, Luis
    Christian, Jennifer B.
    Scalfaro, Erik
    Dreyer, Nancy A.
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [35] Real-World Treatment Patterns in Patients with Vitiligo in the United States
    David Rosmarin
    Ahmed M. Soliman
    Chao Li
    Dermatology and Therapy, 2023, 13 : 2079 - 2091
  • [36] Real-World Treatment Patterns in Patients with Vitiligo in the United States
    Rosmarin, David
    Soliman, Ahmed
    Li, Chao
    DERMATOLOGY AND THERAPY, 2023, 13 (09) : 2079 - 2091
  • [37] Real-World Data on Heart Failure Readmission Reduction Real or Real Uncertain?
    Krumholz, Harlan M.
    Dhruva, Sanket S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (19) : 2366 - 2368
  • [38] Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011–2021
    Rohit Shankar
    Xiaocong Li Marston
    Vanessa Danielson
    Bronwyn Do Rego
    Reginald Lasagne
    Oliver Williams
    Lara Groves
    Journal of Neurology, 2024, 271 : 2473 - 2483
  • [39] Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas
    Demetri, George D.
    Stacchiotti, Silvia
    ONCOLOGY, 2021, 99 (SUPPL 1) : 3 - 7
  • [40] Adding value to real-world data: the role of biomarkers
    Plant, Darren
    Barton, Anne
    RHEUMATOLOGY, 2020, 59 (01) : 31 - 38